HSP90B1 and COVID-19: Meanwhile, the HBV-infected group also displayed higher plasma gp96 levels (788.8 ± 193.4) than the non-COVID-19 group (P = 0.0092) but much lower levels than the severe COVID-19 group (P = 0.0014).